Logo image of CTHR

CHARLES & COLVARD LTD (CTHR) Stock Fundamental Analysis

NASDAQ:CTHR - Nasdaq - US1597652056 - Common Stock - Currency: USD

0.49  -0.04 (-7.55%)

After market: 0.5209 +0.03 (+6.31%)

Fundamental Rating

1

Overall CTHR gets a fundamental rating of 1 out of 10. We evaluated CTHR against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of CTHR have multiple concerns. CTHR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CTHR has reported negative net income.
CTHR had a negative operating cash flow in the past year.
In multiple years CTHR reported negative net income over the last 5 years.
In multiple years CTHR reported negative operating cash flow during the last 5 years.
CTHR Yearly Net Income VS EBIT VS OCF VS FCFCTHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -35.05%, CTHR is doing worse than 91.84% of the companies in the same industry.
CTHR's Return On Equity of -56.00% is on the low side compared to the rest of the industry. CTHR is outperformed by 79.59% of its industry peers.
Industry RankSector Rank
ROA -35.05%
ROE -56%
ROIC N/A
ROA(3y)-23.89%
ROA(5y)-12.91%
ROE(3y)-33.75%
ROE(5y)-18.62%
ROIC(3y)N/A
ROIC(5y)N/A
CTHR Yearly ROA, ROE, ROICCTHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

CTHR's Gross Margin of 29.68% is on the low side compared to the rest of the industry. CTHR is outperformed by 81.63% of its industry peers.
CTHR's Gross Margin has declined in the last couple of years.
CTHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.41%
GM growth 5Y-8.94%
CTHR Yearly Profit, Operating, Gross MarginsCTHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

CTHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
CTHR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CTHR has less shares outstanding
The debt/assets ratio for CTHR is higher compared to a year ago.
CTHR Yearly Shares OutstandingCTHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CTHR Yearly Total Debt VS Total AssetsCTHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -2.18, we must say that CTHR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CTHR (-2.18) is worse than 87.76% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that CTHR is not too dependend on debt financing.
The Debt to Equity ratio of CTHR (0.09) is better than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z -2.18
ROIC/WACCN/A
WACC8.28%
CTHR Yearly LT Debt VS Equity VS FCFCTHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.33 indicates that CTHR should not have too much problems paying its short term obligations.
With a Current ratio value of 1.33, CTHR is not doing good in the industry: 77.55% of the companies in the same industry are doing better.
CTHR has a Quick Ratio of 1.33. This is a bad value and indicates that CTHR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.80, CTHR is not doing good in the industry: 75.51% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.8
CTHR Yearly Current Assets VS Current LiabilitesCTHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

CTHR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -219.50%.
CTHR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.68%.
CTHR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.40% yearly.
EPS 1Y (TTM)-219.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-484.93%
Revenue 1Y (TTM)-26.68%
Revenue growth 3Y-17.59%
Revenue growth 5Y-7.4%
Sales Q2Q%-31.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTHR Yearly Revenue VS EstimatesCTHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CTHR Yearly EPS VS EstimatesCTHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 0 1 -1 2 3 4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CTHR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTHR Price Earnings VS Forward Price EarningsCTHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CTHR Per share dataCTHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CTHR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHARLES & COLVARD LTD

NASDAQ:CTHR (4/24/2025, 8:01:39 PM)

After market: 0.5209 +0.03 (+6.31%)

0.49

-0.04 (-7.55%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)04-30 2025-04-30
Earnings (Next)N/A N/A
Inst Owners7.03%
Inst Owner Change0%
Ins Owners21.21%
Ins Owner Change0%
Market Cap1.53M
Analysts82.86
Price TargetN/A
Short Float %4.06%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.06
P/tB 0.06
EV/EBITDA N/A
EPS(TTM)-2.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.69
FCFYN/A
OCF(TTM)-2.36
OCFYN/A
SpS7.04
BVpS8.22
TBVpS8.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.05%
ROE -56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.68%
FCFM N/A
ROA(3y)-23.89%
ROA(5y)-12.91%
ROE(3y)-33.75%
ROE(5y)-18.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.41%
GM growth 5Y-8.94%
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 147.56%
Cap/Sales 4.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.8
Altman-Z -2.18
F-Score3
WACC8.28%
ROIC/WACCN/A
Cap/Depr(3y)223.22%
Cap/Depr(5y)172.85%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-219.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-484.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.68%
Revenue growth 3Y-17.59%
Revenue growth 5Y-7.4%
Sales Q2Q%-31.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-62.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-90.07%
OCF growth 3YN/A
OCF growth 5YN/A